Economic Impact of Oral Therapies for Chronic Lymphocytic Leukemia—the Burden of Novelty

Overview of attention for article published in Current Hematologic Malignancy Reports, July 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 64,095 followers.

RT @THilalMD: Our paper discussing cost of #CLL therapies is out. Might have included some controversial arguments. Nevertheless, rising dr…

11 Jul 2018

Reply Repost Favourite

@AmeetSarpatwari Not as eloquently presented, but we discussed most of these in this paper: https://t.co/GA4HWq2Spb

11 Jul 2018

Reply Repost Favourite

RT @THilalMD: Our paper discussing cost of #CLL therapies is out. Might have included some controversial arguments. Nevertheless, rising dr…

09 Jul 2018

Reply Repost Favourite

RT @THilalMD: Our paper discussing cost of #CLL therapies is out. Might have included some controversial arguments. Nevertheless, rising dr…

09 Jul 2018

Reply Repost Favourite

RT @THilalMD: Our paper discussing cost of #CLL therapies is out. Might have included some controversial arguments. Nevertheless, rising dr…

09 Jul 2018

Reply Repost Favourite

Our paper discussing cost of #CLL therapies is out. Might have included some controversial arguments. Nevertheless, rising drug costs is not an issue that can be addressed with a single intervention. Or can it? #pbm https://t.co/TFfWmQFcb2 #ibrutinib #idel

09 Jul 2018

Reply Repost Favourite